SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001214659-20-009284
Filing Date
2020-11-10
Accepted
2020-11-10 16:53:30
Documents
47
Period of Report
2020-09-30

Document Format Files

Seq Description Document Type Size
1 d11620010q.htm 10-Q 513859
2 EXHIBIT 31.1 ex31_1.htm EX-31.1 7491
3 EXHIBIT 31.2 ex31_2.htm EX-31.2 7824
4 EXHIBIT 32.1 ex32_1.htm EX-32.1 4332
5 EXHIBIT 32.2 ex32_2.htm EX-32.2 4390
12 GRAPHIC chart1.jpg GRAPHIC 24421
13 GRAPHIC chart2.jpg GRAPHIC 43105
  Complete submission text file 0001214659-20-009284.txt   2802101

Data Files

Seq Description Document Type Size
6 XBRL INSTANCE FILE hgen-20200930.xml EX-101.INS 323138
7 XBRL SCHEMA FILE hgen-20200930.xsd EX-101.SCH 45739
8 XBRL CALCULATION FILE hgen-20200930_cal.xml EX-101.CAL 33440
9 XBRL DEFINITION FILE hgen-20200930_def.xml EX-101.DEF 143792
10 XBRL LABEL FILE hgen-20200930_lab.xml EX-101.LAB 306850
11 XBRL PRESENTATION FILE hgen-20200930_pre.xml EX-101.PRE 204232
Mailing Address 533 AIRPORT BLVD. SUITE 400 BURLINGAME CA 94010
Business Address 533 AIRPORT BLVD. SUITE 400 BURLINGAME CA 94010 650.243.3100
HUMANIGEN, INC (Filer) CIK: 0001293310 (see all company filings)

IRS No.: 770557236 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-35798 | Film No.: 201301878
SIC: 2834 Pharmaceutical Preparations